NCT00186576View on ClinicalTrials.gov

Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

March 31, 2004

Study Completion Date

July 31, 2010

Conditions
Myelodysplastic SyndromesMyeloproliferative DisordersBlood and Marrow Transplant (BMT)Myelodysplastic Syndromes (MDS)Myeloproliferative Disorders (MPD)
Interventions
PROCEDURE

nonmyeloablative allogeneic hematopoietic cell transplant

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Stanford University

OTHER

NCT00186576 - Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders | Biotech Hunter | Biotech Hunter